Community Practice Connections™: Optimizing SCLC Treatment Strategies and Managing Adverse Events Across Disease Stages

Release Date: November 25, 2025

Expiration Date: November 25, 2026

Activity Overview

Consolidation and maintenance therapy are crucial in helping patients with small cell lung cancer (SCLC) retain the gains they made with first-line therapy. Immunotherapy options have demonstrated a benefit in both of these settings. Bispecific antibodies and antibody-drug conjugates are also improving outcomes as maintenance or second-line therapies.

This Community Practice Connection™ program provides an in-depth review of some of the key highlights from an Association of Cancer Care Centers virtual webcast series on current and emerging therapies in limited-stage and extensive-stage SCLC. This unique and engaging multimedia activity is ideal for the community-based clinician. It focuses on clinical trial data of targeted and immunotherapy. The program is designed for those who did not attend the live meeting and to help reinforce learning for those who did.

Target Audience

This educational program is primarily directed toward community-based oncologists involved in the treatment of SCLC.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Discuss current trial data describing novel strategies for the management of limited- and extensive-stage small cell lung cancer (SCLC)
• Plan strategies to prevent and proactively manage treatment-related adverse events in patients with SCLC
• Apply clinical trial evidence supporting the efficacy and safety of SCLC treatment strategies to optimally manage patients with SCLC in the second- and subsequent-line setting

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.